| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/13/2022 | 55.76% | Morgan Stanley | $21 → $20 | Maintains | Equal-Weight |
| 05/24/2022 | 55.76% | Goldman Sachs | $23 → $20 | Maintains | Buy |
| 04/11/2022 | 63.55% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight |
| 10/26/2021 | 110.28% | B of A Securities | → $27 | Initiates Coverage On | → Buy |
| 10/26/2021 | 94.7% | Morgan Stanley | → $25 | Initiates Coverage On | → Equal-Weight |
| 10/26/2021 | 133.64% | Goldman Sachs | → $30 | Initiates Coverage On | → Buy |
Exscientia Questions & Answers
The latest price target for Exscientia (NASDAQ: EXAI) was reported by Morgan Stanley on June 13, 2022. The analyst firm set a price target for $20.00 expecting EXAI to rise to within 12 months (a possible 55.76% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Exscientia (NASDAQ: EXAI) was provided by Morgan Stanley, and Exscientia maintained their equal-weight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exscientia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exscientia was filed on June 13, 2022 so you should expect the next rating to be made available sometime around June 13, 2023.
While ratings are subjective and will change, the latest Exscientia (EXAI) rating was a maintained with a price target of $21.00 to $20.00. The current price Exscientia (EXAI) is trading at is $12.84, which is out of the analyst's predicted range.